Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Neurocrine Biosciences, Inc shares valued at $147,285 were sold by Delaet Ingrid on Dec 17 ’24. At $135.00 per share, Delaet Ingrid sold 1,091 shares. The insider’s holdings dropped to 2,507 shares worth approximately $0.35 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, INGRID DELAET purchased 1,091 shares, netting a total of over 145,158 in proceeds.
Before that, Onyia Jude had sold 2,331 shares from its account. In a trade valued at $294,373, the Chief Scientific Officer traded Neurocrine Biosciences, Inc shares for $126.29 each. Upon closing the transaction, the insider’s holdings decreased to 2,331 shares, worth approximately $2.15 million.
Analysts at Piper Sandler upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in late August. As of April 24, 2024, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for NBIX.
Analyzing NBIX Stock Performance
During the last five days, there has been a surge of approximately 2.64%. Over the course of the year, Neurocrine Biosciences, Inc shares have jumped approximately 5.52%. Shares of the company reached a 52-week high of $157.98 on 08/01/24 and a 52-week low of $110.95 on 10/03/24. A 50-day SMA is recorded $125.03, while a 200-day SMA reached $133.00. Nevertheless, trading volume fell to 0.92 million shares from 1.28 million shares the previous day.
Support And Resistance Levels for Neurocrine Biosciences, Inc (NBIX)
According to the 24-hour chart, there is a support level at 136.94, which, if violated, would cause prices to drop to 134.86. In the upper region, resistance lies at 140.11. The next price resistance is at 141.19. RSI (Relative Strength Index) is 71.82 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 4.94, which suggests the price will increase in the coming days. Percent R is at 6.74%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
